13F Data
13F filer · CIK 1479355

VHCP Management, LLC

NEW YORK, NY · filing since Q2 2013 · last filing Feb 13, 2017
Reported value
$96.5M
$-18.7M vs prior
Positions
23
New / sold out
2 / 2
Added / reduced
2 / 0
Turnover
5.1%
buys $5.4M · sells $13.2M
Top-10 weight
85.3%

Biggest buys vs Q1 2016

ChangeSecurityShares changeChange %Est. trade value
NewAdverum Biotechnologies+1,102,735–+$3.5M
AddedBioCryst Pharmaceuticals Inc+442,161+78.5%+$1.3M
AddedAlcobra Ltd+138,813+28.7%+$623.3K
NewAeglea BioTherapeutics+6,000–+$29.0K

Biggest sells vs Q1 2016

ChangeSecurityShares changeChange %Est. trade value
Sold outAnacor Pharmaceuticals Inc-140,756-100.0%$-7.5M
Sold outAvalanche Biotechnologies Inc-1,102,735-100.0%$-5.7M

Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.

Reported value by quarter

Q2 2013: $134.7MQ3 2013: $181.1MQ4 2013: $185.8MQ1 2014: $192.4MQ2 2014: $187.1MQ3 2014: $222.5MQ4 2014: $363.5MQ1 2015: $434.3MQ2 2015: $354.5MQ3 2015: $390.1MQ4 2015: $165.5MQ1 2016: $115.2MQ2 2016: $96.5MQ3 2016: $101.7MQ4 2016: $93.0M
Q2 2013Q4 2016

Holdings · Q2 2016

#SecuritySharesValueWeight
1DBV TechnologiesCOM456,893$29.1M30.17%
2Heron Therapeutics IncCOM1,095,734$19.8M20.50%
3Coherus Biosciences IncCOM611,010$10.3M10.69%
4Flamel Technologies S.A.COM500,000$5.4M5.57%
5Zafgen IncCOM602,114$3.6M3.74%
6Adverum BiotechnologiesCOM1,102,735$3.5M3.61%
7BioCryst Pharmaceuticals IncCOM1,005,104$2.9M2.96%
8Alcobra LtdCOM623,313$2.8M2.90%
9Lipocine IncCOM849,921$2.6M2.68%
10Axovant Sciences LtdCOM184,110$2.4M2.45%
13 more rows. Subscribe for $29/month to see every row, download the data and use the API.